Importance of immunometabolic markers for the classification of patients with major depressive disorder using machine learning.
Sánchez-Carro Y, de la Torre-Luque A, Leal-Leturia I, Salvat-Pujol N, Massaneda C, de Arriba-Arnau A, Urretavizcaya M, Pérez-Solà V, Toll A, Martínez-Ruiz A, Ferreirós-Martínez R, Pérez S, Sastre J, Álvarez P, Soria V, López-García P.
Sánchez-Carro Y, et al. Among authors: alvarez p.
Prog Neuropsychopharmacol Biol Psychiatry. 2023 Mar 8;121:110674. doi: 10.1016/j.pnpbp.2022.110674. Epub 2022 Nov 1.
Prog Neuropsychopharmacol Biol Psychiatry. 2023.
PMID: 36332700
Free article.